Quality Medicines Diseases Newsroom Feed back Contact us

Milestones button

Mile Stones in Pharmaceuticals field
Mile Stones in Pharmaceuticals field

2005 Company Strategic Focus Sharpens

  • Three internally developed programs targeting IND enabling studies
  • Enhanced therapeutic area focus on Cancer and Inflammation
  • Strengthened in-house crystallography capabilities
  • Core technology competitiveness demonstrated via crystallography
  • Successful government grant initiatives
  • First patent approval on core technology
  • Signed third molecular design collaboration (P&G)
  • Acquired Protein Mechanics to solidify leadership position in computational drug design

2004 Company and Technology Matures

  • Signed first two molecular design collaborations with DuPont and Speedel
  • Obtained confirmatory and pivotal pre-clinical data
    in lead programs
  • Initiated crystallography effort to support major programs
  • Implemented comprehensive intellectual
    property strategy
  • Strengthened management team
  • Signed IBM collaboration to allow computing on demand

2003 Company Infrastructure Evolves

  • Three programs are identified and experimental proof of
    concept achieved
  • Computational efficiency improved by 400%
  • Introduced proprietary computational tools to improve the
    identification of protein binding sites and small molecule ligands

2002 Company Secures Operational Base

  • Senior chemists, biologists, computer scientists hired
  • Moved into headquarters and laboratory facility in Blue Bell, PA
  • Built powerful Linux supercomputer cluster capable of
    2 trillion calculations/second
  • Enhanced primary fragment set from 20 to 150
  • Initiated internal chemistry and biology efforts in several programs
  • Raised third round of financing: $40MM

2001 Commence Operations

  • Senior management hired
  • in Zilico experiments validate technology platform
  • Raised second round of financing: $42.75MM



All brand names mentioned enjoy legal protection.



  Company   Products   Diseases   Health   Media   R & D   Sustainability  
  Figure & Reports   Investors   Countries   E-mail us      Divisions   Contact us   Home  

         Copyright 2005 TAJ Pharmaceuticals Limited ,434 LAXMI PLAZA (LAXMI INDUSTRIAL ESTATE) NEW LINK ROAD Andheri (W) MUMBAI-53. INDIA

Site Requirements : Internet Explorer 5.0+ or Netscape 5.0+, Flash Player 5.0 & Real Player 8 Basic
To get in touch with us, call on 91-22-2637 4592, 91--22-2637 4593 or fax us at 91-22-2634 1274 

| Privacy Policy | Terms & Conditions | Sitemap |